Free Trial

Smith & Nephew SNATS (SNN) Competitors

Smith & Nephew SNATS logo
$31.66 +0.19 (+0.59%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$31.68 +0.01 (+0.03%)
As of 07/25/2025 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, BLCO, IRTC, and SLNO

Should you be buying Smith & Nephew SNATS stock or one of its competitors? The main competitors of Smith & Nephew SNATS include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

Smith & Nephew SNATS vs. Its Competitors

GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

GE HealthCare Technologies has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500.

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$19.67B1.81$1.99B$4.7516.34
Smith & Nephew SNATS$5.81B2.39$412M$2.1614.66

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays an annual dividend of $0.89 per share and has a dividend yield of 2.8%. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Smith & Nephew SNATS pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

In the previous week, GE HealthCare Technologies had 15 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 3 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 1.42 beat Smith & Nephew SNATS's score of 1.21 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
14 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew SNATS
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

GE HealthCare Technologies has a net margin of 11.02% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 24.95% beat Smith & Nephew SNATS's return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies11.02% 24.95% 6.38%
Smith & Nephew SNATS N/A N/A N/A

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

GE HealthCare Technologies presently has a consensus target price of $88.55, indicating a potential upside of 14.09%. Smith & Nephew SNATS has a consensus target price of $28.00, indicating a potential downside of 11.57%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83
Smith & Nephew SNATS
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

GE HealthCare Technologies beats Smith & Nephew SNATS on 17 of the 20 factors compared between the two stocks.

Get Smith & Nephew SNATS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNN vs. The Competition

MetricSmith & Nephew SNATSMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$13.79B$10.55B$5.69B$21.10B
Dividend Yield2.81%2.00%4.58%3.59%
P/E Ratio14.6617.0728.1028.44
Price / Sales2.3929.17432.4458.59
Price / Cash9.9723.0336.2222.92
Price / Book2.633.698.664.69
Net Income$412M$234.77M$3.25B$995.51M
7 Day Performance5.06%6.32%4.23%1.65%
1 Month Performance4.86%7.94%10.52%4.54%
1 Year Performance9.45%-13.57%34.41%9.99%

Smith & Nephew SNATS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNN
Smith & Nephew SNATS
2.7209 of 5 stars
$31.67
+0.6%
$28.00
-11.6%
+9.4%$13.79B$5.81B14.6617,349News Coverage
Positive News
GEHC
GE HealthCare Technologies
4.2644 of 5 stars
$74.45
-0.9%
$88.55
+18.9%
-2.9%$34.09B$19.80B15.6753,000Positive News
Upcoming Earnings
PHG
Koninklijke Philips
2.7208 of 5 stars
$24.07
+0.1%
N/A+1.6%$23.17B$17.98B55.9766,678Upcoming Earnings
ZBH
Zimmer Biomet
4.9443 of 5 stars
$93.79
flat
$110.00
+17.3%
-11.8%$18.56B$7.68B20.7517,000Positive News
SOLV
Solventum
0.768 of 5 stars
$74.08
+0.4%
$81.50
+10.0%
+29.9%$12.82B$8.25B34.3022,000Positive News
PEN
Penumbra
4.4474 of 5 stars
$238.82
+0.4%
$305.07
+27.7%
+22.7%$9.25B$1.24B225.314,500Positive News
Upcoming Earnings
Insider Trade
STVN
Stevanato Group
1.3232 of 5 stars
€25.55
+1.3%
N/A+32.3%€7.74B€1.12B50.105,521News Coverage
GKOS
Glaukos
4.2468 of 5 stars
$104.43
+0.6%
$134.67
+29.0%
-19.9%$5.97B$404.52M-44.06780Positive News
Upcoming Earnings
BLCO
Bausch + Lomb
1.8866 of 5 stars
$13.67
-1.5%
$15.45
+13.1%
-8.3%$4.83B$4.83B-13.2713,500Upcoming Earnings
IRTC
iRhythm Technologies
1.0226 of 5 stars
$138.91
+2.2%
$138.60
-0.2%
+41.3%$4.43B$591.84M-44.242,000Upcoming Earnings
SLNO
Soleno Therapeutics
4.1957 of 5 stars
$82.76
+1.5%
$108.70
+31.3%
+84.2%$4.17BN/A-17.9130Positive News
Analyst Upgrade
High Trading Volume

Related Companies and Tools


This page (NYSE:SNN) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners